Evolent, Health

Evolent Health Sells Primary Care Division in Strategic Shift

Published on 09/24/2025 at 10:27 | Redaktion boerse-global.de

Strategic Focus on Specialty Care

Evolent Health Sells Primary Care Division in Strategic Shift Illustration mit AI erstellt übermittelt durch boerse-global.de
Evolent Health Sells Primary Care Division in Strategic Shift Illustration mit AI erstellt übermittelt durch boerse-global.de

Evolent Health has announced the divestiture of its Evolent Care Partners division to Privia Health Group in a transaction valued at up to $113 million. The healthcare company’s shares experienced initial volatility following the news, declining 2.33 percent to $8.39 before recovering with a 2.09 percent gain in after-hours trading.

The sale marks a significant strategic pivot for Evolent Health, enabling the company to concentrate resources on its core specialty care business. This segment focuses on value-based treatment for complex conditions such as cancer and cardiovascular disease. The divested primary care unit currently manages care for more than 120,000 members through various programs, including Medicare Advantage and commercial health plans.

Transaction specifics include an immediate cash payment of $100 million upon closure, with an... Read more...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US30050B1017 | EVOLENT | boerse | 68218953 |